Page last checked 2026-08-16

Canada · peptide status

Are peptides legal in Canada? Check the product, not the category

Peptides are not legal or illegal as one group in Canada. Health Canada says they are generally prescription drugs. An authorized product has an eight-digit Drug Identification Number and a Drug Product Database record. Health Canada calls unauthorized drug products illegal. Its seized examples include BPC-157, CJC-1295, GHK-Cu, ipamorelin, MOTS-C, TB-500 and retatrutide.

Source: Health Canada guidance, checked 2026-08-16

1 · Product

Does this exact product have a DIN?

Authorization belongs to a product, not an ingredient category.

2 · Channel

Who is prescribing and supplying it?

Authorized use runs through licensed care and pharmacy channels.

3 · Import

Is the person a resident or visitor?

Canada does not give residents a general personal-import exemption.

Start with authorization

Three checks for one exact product

Health Canada advisory · 9 April 2026

A DIN is the shortest useful check, but it is not the only one. Match the number and product in the Drug Product Database. Then match the maker and the care channel.

How to check a peptide product’s Canadian authorization, reviewed 16 August 2026.
Check	What it establishes	What it does not establish
DIN on the label	Authorized prescription drugs carry an eight-digit Drug Identification Number.	A number printed by a seller is not enough. Verify the product in Health Canada’s database.
Drug Product Database	The nightly database lists drugs authorized for sale. It also records their Canadian availability.	Authorization belongs to the exact product, dosage form and manufacturer—not to the word peptide.
Licensed care channel	Authorized peptide drugs are used under a licensed professional and bought from a licensed pharmacy.	A clinic claim or a “Canada” label on a website does not establish authorization.

The named examples

What Health Canada seized and called unauthorized

Health Canada’s April 2026 advisory names the products below as examples. It also warns that other unauthorized peptide drugs exist, so this is not a complete approval list in reverse.

BPC-157
CJC-1295
DSIP
Epitalon
GHK-Cu
HCG
Ipamorelin
KPV
Melanotan I and II
MOTS-C
NAD+
SS-31
TB-500
retatrutide

What “research use only” changes

Nothing about Canadian drug authorization. Health Canada addresses research use only and not for human consumption labels. They do not make an unauthorized drug legal. They also do not remove the rules that apply to it.

Access is a separate question

Marketed access, Special Access and trials are not interchangeable

An authorized Canadian product follows its ordinary prescribing and pharmacy route. Special Access is a narrow emergency pathway for a practitioner. A trial is research, not ordinary availability.

The Canadian routes that can put a peptide product under clinical oversight.
Route	How it works	Boundary
Authorized Canadian product	A licensed healthcare professional treats a specific condition. A licensed pharmacy supplies the product.	Confirm the exact product’s DIN and current Drug Product Database record.
Special Access Program	A health or dental practitioner may request a drug that is not sold in Canada for a patient in a medical emergency.	Patients cannot apply directly. The condition must be serious or life-threatening and ordinary options must have failed, be unsuitable or be unavailable.
Clinical trial	A participant may receive an investigational product under the trial’s protocol and oversight.	Trial participation is not market authorization or ordinary retail access.

Who can ask for Special Access

A health or dental practitioner applies. They must act for a patient under their care. Patients cannot apply directly. Health Canada reviews each request on its own. Authorization is not full market approval.

Personal import

The resident rule is stricter than the visitor rule

No blanket resident exemption

Canadian residents are generally not allowed to bring prescription drugs into Canada or receive them by mail or courier. Health Canada lists narrow continuity and trial situations. Visitors have a different personal-use route.

How Health Canada separates resident, visitor and commercial import cases.
Situation	Default rule	Boundary or exception
Canadian resident	Generally not allowed to bring or receive prescription drugs from outside Canada.	Narrow continuation and foreign-sponsored trial situations may permit a 90-day supply or one course of treatment.
Visitor to Canada	May bring a personal quantity. It must be for the visitor or someone traveling under their care.	The quantity is generally no more than a 90-day supply or one course. Visitor status and proper packaging must be clear.
Seller, giver or practitioner import	It is not personal import when the product is for sale or advertising. Giving it to another person or treating a patient also changes the route.	Commercial and practitioner imports follow separate licensing and access rules.

Questions people actually ask

Can you get peptide therapy in Canada?

Start with the exact product. An authorized product should have a DIN and a current Drug Product Database record. Licensed care and pharmacy channels should supply it. A clinic cannot turn an unauthorized product into ordinary therapy through marketing.

Are peptides legal for personal use?

There is no single rule for every peptide. Product authorization matters. How you got the product matters too. Health Canada says unauthorized drug products are illegal. Canadian residents also lack a general import route for prescription drugs.

Can I buy peptides in Canada?

Health Canada directs people to licensed pharmacies for authorized prescription drugs. A licensed healthcare professional should oversee their use. Check the exact DIN in the Drug Product Database. Do not rely on a seller’s country name or research disclaimer.

Can a Canadian resident import peptides for personal use?

Not as a general rule when the product is a prescription drug. Health Canada says residents are generally not allowed to carry or receive prescription drugs from abroad. It lists narrow situations, usually limited to a 90-day supply or one course of treatment.

What remains uncertain

It does not put every peptide or peptide-containing product into one legal group.
A DIN proves authorization for the exact product; it does not authorize other products with a similar ingredient name.
Special Access is not routine availability, a patient application or full market approval.
A 90-day quantity limit does not create an import right where the person or product is otherwise ineligible.

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewer

Reviewed 2026-08-16

Health Canada names these examples in one advisory. Their authorization status and human evidence still answer different questions, so each compound keeps its own page.

Continue through the page

The routes nobody here ranks or sells

4 questions the section refuses outright, each with the reason printed beside it.

What retatrutide costs through each route

Retatrutide turns up in FDA’s published warning letters even though no approved product exists, which tells you what the letters are about.

Where the UK Mounjaro page stops

England’s rollout is not copied onto Scotland, Wales or Northern Ireland.

What Wegovy’s UK price means

£9.90 per item unless exempt is the English prescription charge per item, not Wegovy’s drug price.

What the source labels on this page mean

How an FDA label differs from a human trial, limited human data or no established human dose.

Sources

Think twice before injecting peptides bought online · Health Canada · retrieved 2026-08-16
Bringing health products into Canada for personal use · Health Canada · retrieved 2026-08-16
Drug Product Database: Access the database · Health Canada · retrieved 2026-08-16
Information for patients on the Special Access Program · Health Canada · retrieved 2026-08-16